Translational Development Acquisition
TDAC | NASDAQ
$10.86
-$0.02 (-0.18%)
At close: Nov 16, 2026, 4:00 PM ET
$10.90
+$0.04 (+0.37%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-0.18%
(1D)No price chart data available for 1D timeframe.
Rating
25.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1127/1269 (Top 89%)
Key Statistics
Market Data
Market Cap $267.48M
1D Range
10.86 10.89
52W Range
10.41 10.91
Valuation (TTM)
PE 41.77
PB 1.79
EV/EBITDA -203.68
Valuation (NTM)
Forward PE N/A
Forward PEG -1.07
Price Target $0.00
Cash Flow
FCF Yield -0.3%
SBC Adj. FCF Yield -0.3%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 100.0% |
N/A
FCF 3Y | 5Y -60.6% |
N/A
Returns
ROA 3.5%
ROE 3.3%
ROIC -0.8%
Financial Health
Net Debt
$1.01M
Current Ratio 0.06
Interest Coverage 170.62
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business ...
Sector Financial Services
Industry Shell Companies
Employees 2
IPO Date Feb 20, 2025
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove TDAC